Examkin

Tüm alıştırma soruları

4736 soru

Tüm türler4,736Çoktan seçmeli2,413Çoklu seçim567Sayısal127Eşleştirme858Sıralama771
Soru 2781Soru →

A hospital ethics committee is reviewing several complex cases regarding end-of-life decision-making and patient autonomy. Pair each patient vignette with the foundational ethical principle or legal standard that best justifies the clinical action taken.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A physician administers high-dose intravenous phenobarbital for refractory terminal restlessness in a dying patient with pancreatic cancer, accepting the secondary risk of fatal respiratory depression.
A designated healthcare proxy refuses hemodialysis for an unconscious trauma patient, referencing multiple past conversations where the patient explicitly rejected life-sustaining treatments if severely neurologically compromised.
A court-appointed guardian authorizes a transition to hospice care for a patient with lifelong profound intellectual disability and terminal metastatic disease, as the patient never possessed the capacity to formulate personal healthcare values.
A fully oriented and competent patient with advanced amyotrophic lateral sclerosis (ALS) formally declines the placement of a percutaneous endoscopic gastrostomy (PEG) tube, fully acknowledging that this decision will result in starvation and death.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios correctly map as follows: the administration of phenobarbital for restlessness aligns with the Principle of Double Effect; the proxy following prior explicit wishes aligns with Substituted Judgment; the guardian acting for a lifelong incapacitated patient aligns with the Best Interests standard; and the competent ALS patient declining a PEG tube aligns with Informed Refusal.
Each matching correctly aligns the clinical context with its governing ethical framework. The Principle of Double Effect protects clinicians providing aggressive symptom management at the end of life when the primary intent is relief, not death. Substituted judgment requires a surrogate to act exactly as the patient would have, necessitating prior known values. The Best Interests standard is reserved for patients whose wishes are unknown or who never possessed capacity. Informed refusal is the fundamental right of a competent adult to decline unwanted care.

Adım Adım Çözüm

1
Analyze the pancreatic cancer vignette to identify the intent versus the secondary outcome.
The intent is symptom relief, with an accepted risk of hastening death.
This dual-outcome scenario requires the application of the Principle of Double Effect.
2
Evaluate the trauma patient vignette to identify the basis of the surrogate's decision.
The proxy uses the patient's previously expressed wishes.
When decisions are made based on what the patient would have wanted, the Substituted Judgment standard applies.
3
Assess the intellectual disability vignette to determine how decisions are made for patients lacking prior capacity.
The guardian must weigh clinical burdens and benefits because the patient's autonomous values are unknown.
Without prior capacity, the Substituted Judgment standard cannot be used, leaving the Best Interests standard as the appropriate framework.
4
Review the ALS vignette to evaluate a competent patient's right to decline care.
The patient possesses capacity and rejects life-sustaining intervention.
This is a direct exercise of the Informed Refusal doctrine.

Anahtar Kavram

Ethical and legal frameworks for end-of-life decision-making
Soru 2782Soru →

Emergency medical services bring a 79-year-old male to the emergency department due to severe shortness of breath. The patient has a known history of end-stage heart failure with reduced ejection fraction and stage 5 chronic kidney disease (baseline creatinine 3.9 mg/dL). Upon arrival, he is lethargic, obtunded, and incapable of meaningfully participating in his medical care. He exhibits profound respiratory distress with prominent use of accessory muscles.

His daughter accompanies him and provides the physician with legal documentation establishing her as the designated healthcare proxy, alongside a valid advance directive. The directive explicitly refuses endotracheal intubation and cardiopulmonary resuscitation, requesting only symptom-directed comfort care. Shortly thereafter, the patient's estranged son arrives. He becomes visibly upset, demanding that the patient be immediately intubated and transferred to the intensive care unit, threatening litigation if aggressive life-sustaining measures are withheld.

The attending physician concludes that intubation contradicts both the documented advance directive and the proxy's instructions. Meanwhile, the daughter urgently asks for medications to relieve her father's severe breathing difficulty.

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Administer low-dose intravenous hydromorphone and admit the patient for comfort-focused care

Cevap

Administer low-dose intravenous hydromorphone and admit the patient for comfort-focused care.
The most appropriate next step is to administer low-dose intravenous hydromorphone to relieve the patient's severe dyspnea and admit him for comfort-focused care. The patient lacks clinical decision-making capacity, so his legally designated healthcare proxy (the daughter) has the authority to direct his care. Her request aligns with the patient's valid advance directive, which refuses intubation. Therefore, the estranged son's demands must be respectfully declined. Furthermore, for managing dyspnea in a patient with severe chronic kidney disease, hydromorphone or fentanyl is preferred over morphine because morphine has active metabolites (e.g., morphine-6-glucuronide) that accumulate in renal failure and cause significant neurotoxicity.

Adım Adım Çözüm

1
Assess the patient's clinical capacity to make medical decisions.
The patient is lethargic and obtunded, meaning he lacks the clinical capacity to direct his own care.
Establishing capacity determines whether the patient or a surrogate decision-maker has authority over current treatment choices.
2
Identify the legally appropriate surrogate decision-maker.
The daughter is the designated healthcare proxy and presents a valid advance directive.
A legally appointed healthcare proxy supersedes the wishes of other family members, such as the estranged son, within the surrogate hierarchy.
3
Select the appropriate pharmacological intervention for refractory dyspnea in the setting of severe renal impairment.
Intravenous hydromorphone is chosen to relieve distress.
Opioids are the treatment of choice for end-of-life dyspnea. Hydromorphone is preferred over morphine in stage 5 chronic kidney disease to prevent the accumulation of neurotoxic metabolites.

Anahtar Kavram

When a patient lacks clinical capacity, medical decisions are guided by their advance directive and legally designated healthcare proxy, superseding conflicting demands from other family members. Refractory dyspnea at the end of life is managed with opioids, utilizing agents like hydromorphone for patients with severe chronic kidney disease to avoid metabolite toxicity.
Tahmini Süre:1m 30s
Soru 2783Soru →

A large psychiatric hospital is preparing to implement a new continuous vital sign monitoring wearable device for patients receiving rapid tranquilization for acute agitation. The hospital's risk management committee wants to identify and mitigate potential vulnerabilities in how nursing staff will respond to the device's alarms before the devices are deployed on the clinical units. A multidisciplinary team is assembled to map the anticipated workflow and brainstorm how the alarm response process might fail. The team then scores each potential failure based on its clinical severity, probability of occurrence, and likelihood of detection. Safeguards are subsequently designed to address the highest-scoring vulnerabilities. Which of the following best describes the methodology the team is utilizing?

Cevabı ve açıklamayı göster

Cevap: Failure Mode and Effects Analysis

Cevap

Failure Mode and Effects Analysis
The correct answer is Failure Mode and Effects Analysis (FMEA). FMEA is a proactive, prospective quality improvement methodology used to systematically evaluate a process to identify where and how it might fail, and to assess the relative impact of different failures before they reach the patient. The defining characteristics of FMEA described in the scenario include occurring prior to system implementation and scoring potential failures based on severity, probability of occurrence, and likelihood of detection (which are multiplied together to calculate a Risk Priority Number, or RPN). Interventions are then targeted at the steps with the highest RPNs.

Adım Adım Çözüm

1
Analyze the timing and goal of the quality improvement intervention described in the scenario.
The intervention is taking place 'before the devices are deployed' to preemptively identify vulnerabilities, indicating a prospective, proactive approach.
Determining whether the analysis is prospective (before an event) or retrospective (after an event) is the critical first step in identifying the correct QI methodology.
2
Evaluate the specific activities and calculations performed by the multidisciplinary team.
The team maps the anticipated workflow, brainstorms potential failures, and scores them based on severity, probability of occurrence, and likelihood of detection.
These specific components (identifying failure modes and calculating a risk score based on severity, occurrence, and detection) are the defining features of a specific analytical tool.
3
Match the identified characteristics with the appropriate quality improvement framework.
A prospective analysis that anticipates failures and scores them using these three specific variables is characteristic of Failure Mode and Effects Analysis (FMEA).
FMEA is uniquely designed for prospective hazard analysis and utilizes these exact scoring metrics to generate a Risk Priority Number for each potential failure.

Anahtar Kavram

Failure Mode and Effects Analysis (FMEA) is a prospective, proactive quality improvement tool used to identify, score, and mitigate potential system failures before a new process is implemented or an adverse event occurs.
Soru 2784Soru →

During an annual wellness evaluation, a physician is discussing preventive health measures with a healthy individual who recently turned 52. The individual has a 35-pack-year smoking history and currently smokes one pack of cigarettes daily. When the physician introduces the topic of low-dose computed tomography for lung cancer screening, the individual abruptly crosses their arms and says, "I am not doing any cancer tests. Every time I come here, I get a lecture about my habits. My uncle smoked his whole life and died peacefully at 95." Which of the following is the most appropriate initial communication strategy for the physician to employ?

Cevabı ve açıklamayı göster

Cevap: It sounds like you feel frustrated when we discuss your smoking. Can we explore your specific concerns about the lung scan?

Cevap

The most appropriate response uses reflective listening to acknowledge the patient's frustration without judgment, followed by an open-ended question to explore their specific reservations about the screening test.
The correct response utilizes reflective listening to validate the patient's emotional experience without agreeing with their behavior. By stating, 'It sounds like you feel frustrated...', the physician de-escalates the patient's defensiveness. This is immediately followed by an open-ended question to gently steer the conversation back to the specific screening test, fostering a collaborative patient-physician relationship rather than an adversarial one.

Adım Adım Çözüm

1
Analyze the patient's emotional state and primary barrier.
The patient is defensive and expects to be judged or lectured regarding their smoking habits.
Recognizing the underlying emotion is required before any medical facts or guidelines can be successfully communicated.
2
Evaluate the communication options based on principles of motivational interviewing.
Responses that argue, threaten, or prematurely pivot to medical management will increase patient resistance.
Directly challenging a defensive patient damages the therapeutic alliance and violates patient-centered counseling principles.
3
Select the response that builds rapport and addresses the emotional barrier.
The response validating the patient's frustration and asking an open-ended question is chosen.
Reflective listening de-escalates tension and allows the physician to smoothly transition back to discussing the screening test collaboratively.

Anahtar Kavram

Handling Patient Resistance and Reflective Listening
Tahmini Süre:1m 0s
Soru 2785Soru →

A 54-year-old biological female presents to the clinic for a routine health maintenance visit. Her medical history is significant for hypertension, hyperlipidemia, and chronic kidney disease stage 3a with a baseline estimated glomerular filtration rate of 52 mL/min/1.73 m². She is a former smoker who smoked 1.5 packs of cigarettes per day from age 37 to age 49 (a total of 12 years) before quitting completely 5 years ago. Current medications include lisinopril and rosuvastatin. Her body mass index is 29 kg/m².

Vaccination history:
- Up to date on seasonal influenza and COVID-19 vaccines.
- Received a Tdap booster 4 years ago after a minor kitchen laceration.
- Received two doses of the recombinant zoster vaccine at age 51.
- She has never received a pneumococcal vaccine.

Screening history:
- Screening colonoscopy at age 48 was completely normal.
- Pap smear with HPV co-testing 3 years ago was negative for intraepithelial lesion or malignancy.
- Hepatitis C virus antibody testing at age 50 was negative.
- Screening mammography 11 months ago was interpreted as BI-RADS 1 (negative).

Which of the following is the most appropriate next step in preventive care and screening for this patient today?

Cevabı ve açıklamayı göster

Cevap: Administration of 20-valent pneumococcal conjugate vaccine

Cevap

Administration of 20-valent pneumococcal conjugate vaccine
The correct answer is the administration of the 20-valent pneumococcal conjugate vaccine (PCV20). According to current ACIP guidelines, adults aged 19-64 with certain underlying medical conditions—including chronic kidney disease (CKD), chronic heart or lung disease, diabetes, and current smoking—are at increased risk for pneumococcal disease and should receive pneumococcal vaccination. Because this patient has CKD stage 3a and has never received a pneumococcal vaccine, a single dose of PCV20 is indicated today.

Adım Adım Çözüm

1
Calculate the patient's smoking pack-years to evaluate lung cancer screening eligibility.
1.5 packs per day multiplied by 12 years equals 18 pack-years.
USPSTF guidelines require a minimum of 20 pack-years for low-dose CT screening. She fails to meet this quantitative threshold.
2
Review the patient's current age and chronic medical conditions against ACIP immunization schedules.
The patient is 54 years old and has chronic kidney disease (CKD) stage 3a.
While routine pneumococcal vaccination begins at age 65, adults aged 19-64 with specific high-risk conditions (including CKD) are indicated to receive it early.
3
Verify the intervals of her recent cancer screenings.
Mammogram was 11 months ago (due every 2 years), Pap/HPV was 3 years ago (due every 5 years), and colonoscopy was 6 years ago (due every 10 years).
Ensures no routine cancer screenings are prematurely ordered before their guideline-directed intervals.

Anahtar Kavram

Application of quantitative thresholds in preventive screening and condition-specific immunization indications for adults under 65.
Tahmini Süre:1m 30s
Soru 2786Soru →

A 42-year-old woman visits the outpatient clinic for a general wellness examination. She feels well and has no specific health concerns. Her medical history is unremarkable, and she takes no daily medications. Her family history is notable for a mother with cervical cancer at age 55, but there is no family history of breast, ovarian, or colon cancer. Menarche occurred at age 13, and she has regular menstrual cycles. Vital signs are within normal limits. Physical examination, including a clinical breast examination, reveals no abnormalities. She has never undergone any breast imaging.

Based on current United States Preventive Services Task Force (USPSTF) guidelines, which of the following is the most appropriate next step in management for this patient?

Cevabı ve açıklamayı göster

Cevap: Order a screening mammogram

Cevap

Order a screening mammogram
The correct action is to order a screening mammogram. The United States Preventive Services Task Force (USPSTF) updated its guidelines to recommend biennial screening mammography for all average-risk women starting at age 40 and continuing until age 74. Because this patient is 42 years old and has never undergone breast imaging, it is clinically indicated to initiate screening at this wellness visit.

Adım Adım Çözüm

1
Identify the patient's demographic and breast cancer risk profile.
The patient is a 42-year-old female with a normal breast examination and no family history of breast or ovarian cancer, placing her at average risk.
Risk stratification dictates the appropriate screening modality and the starting age for interventions.
2
Apply the current United States Preventive Services Task Force (USPSTF) breast cancer screening guidelines.
The USPSTF recommends biennial screening mammography for all women aged 40 to 74 years.
Standardizing care using current evidence-based guidelines ensures early detection and reduces mortality.
3
Determine the next best step in management for this specific patient.
Because she is 42 years old and has never been screened, the immediate next step is to order a screening mammogram.
Initiating screening now aligns perfectly with the recommendation to start at age 40.

Anahtar Kavram

The USPSTF recommends biennial screening mammography for all women aged 40 to 74 years.
Soru 2787Soru →

A 32-year-old woman is currently managed in the intensive care unit for acute respiratory distress syndrome secondary to severe viral pneumonitis. She has been mechanically ventilated and deeply sedated for the past two weeks. The critical care team determines that a tracheostomy is now medically indicated to facilitate weaning from the ventilator. The patient is unmarried, and her parents are deceased. She has lived with her long-term boyfriend for the past eight years. Her only living relative is an older sister who resides in a neighboring state. The patient has no written advance directive and has not legally designated a healthcare proxy. When discussing the proposed procedure, the boyfriend adamantly refuses the tracheostomy, stating he is certain she would never want to live with a 'hole in her neck.' The sister is contacted by telephone and requests that the medical team proceed with the tracheostomy to give the patient the best chance at recovery. Which of the following is the most appropriate course of action for the physician?

Cevabı ve açıklamayı göster

Cevap: Follow the sister's directive because she is the legally recognized surrogate decision-maker.

Cevap

The physician should follow the directive of the patient's sister, as she is the legally authorized surrogate decision-maker.
When a patient lacks decision-making capacity and has no advance directive or legally designated healthcare proxy (such as a durable power of attorney for healthcare), physicians must rely on the statutory surrogate hierarchy to obtain consent. While state laws can vary slightly, the standard hierarchy prioritizes a legal spouse, followed by adult children, parents, and then adult siblings. Although the boyfriend may have intimate knowledge of the patient's values due to their long-term cohabitation, he has no automatic legal standing to make medical decisions on her behalf. Therefore, the adult sister is the legally recognized surrogate, and her directive regarding the tracheostomy should be followed.

Adım Adım Çözüm

1
Assess the patient's ability to make medical decisions.
The patient is deeply sedated and mechanically ventilated, meaning she lacks clinical decision-making capacity.
Before turning to a surrogate, the physician must confirm the patient cannot make decisions for herself.
2
Check for formal advance directives or a designated healthcare proxy.
No written advance directive or durable power of attorney for healthcare exists.
A legally designated proxy or written directive always supersedes the default statutory surrogate hierarchy.
3
Apply the statutory surrogate hierarchy to the available individuals.
The hierarchy is spouse > adult children > parents > adult siblings. The sister is the highest-ranking legally recognized relative.
Without formal legal documentation, unmarried partners do not have surrogate decision-making authority, regardless of the length or closeness of the relationship.

Anahtar Kavram

In the absence of a designated healthcare proxy or advance directive, medical decisions for an incapacitated patient are governed by a statutory surrogate hierarchy. Unmarried partners generally have no legal standing without explicit formal designation.
Soru 2788Soru →

Match each patient presentation from the primary care clinic with the most appropriate next step in preventive screening according to current United States Preventive Services Task Force (USPSTF) guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

21-year-old healthy female presenting for her first well-woman examination
58-year-old male with a 30-pack-year smoking history who currently smokes
68-year-old female with no history of fractures presenting for a routine check-up
46-year-old average-risk male presenting for an annual physical evaluation

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 21-year-old female should receive cervical cytology; the 58-year-old male smoker should undergo a low-dose CT of the chest; the 68-year-old female requires a DEXA scan; and the 46-year-old male should begin colorectal cancer screening.
Each patient demographic profile aligns exclusively with one major Grade A or B USPSTF recommendation. Age 21 is the universal starting point for cervical screening. Age 45 is the universal starting point for colorectal cancer screening. Age 65 is the universal starting point for osteoporosis screening in women. Age 50 combined with a 20 pack-year smoking history serves as the threshold for lung cancer screening.

Adım Adım Çözüm

1
Assess the 21-year-old female's screening requirements based on age.
Identify the need for cervical cancer screening.
Guidelines mandate the initiation of Pap smears at age 21 for all individuals with a cervix.
2
Evaluate the 58-year-old male's risk factors.
Identify the need for lung cancer screening.
His age and 30-pack-year smoking history meet the strict criteria for annual LDCT.
3
Determine the age-based screening needs for the 68-year-old female.
Identify the need for osteoporosis screening.
All women aged 65 and older qualify for baseline DEXA scanning.
4
Review the 46-year-old male's gastrointestinal cancer screening eligibility.
Identify the need for colorectal screening.
The initiation age for average-risk colorectal cancer screening is 45 years.

Anahtar Kavram

Age and risk-based application of USPSTF preventive screening guidelines.
Soru 2789Soru →

A 65-year-old man hospitalized for acute decompensated heart failure is inadvertently administered 50 mg of intravenous hydralazine instead of the prescribed 5 mg. The error occurs shortly after the morning nursing shift change. The patient subsequently develops profound hypotension requiring emergent transfer to the intensive care unit. He is stabilized with vasopressor support and eventually discharged without permanent sequelae. Following the incident, the hospital's risk management department convenes a multidisciplinary committee. The members are tasked with interviewing the involved personnel, reviewing the electronic health record, and mapping out a chronological timeline of the morning's events to identify the latent systemic vulnerabilities that permitted the medication error. Which of the following quality improvement methodologies is the committee actively conducting?

Cevabı ve açıklamayı göster

Cevap: Root cause analysis

Cevap

Root cause analysis
The scenario describes a sentinel event (a severe medication error causing patient harm) that has already occurred. The multidisciplinary committee is conducting a retrospective investigation by collecting data, interviewing staff, and creating a timeline to identify systemic issues. This process is the hallmark of a root cause analysis, which aims to understand why an event happened and identify latent vulnerabilities in the healthcare system to prevent recurrence.

Adım Adım Çözüm

1
Analyze the timing of the quality improvement intervention relative to the adverse event.
The medication error and subsequent patient harm have already occurred, necessitating a retrospective investigation.
Differentiating between retrospective and prospective quality improvement tools is the critical first step.
2
Evaluate the specific activities being performed by the multidisciplinary committee.
The committee is gathering data, interviewing staff, and creating a chronological timeline to find latent system errors.
These actions characterize the standard approach to investigating a sentinel event in healthcare.
3
Identify the methodology that matches these characteristics.
A retrospective, comprehensive system-level investigation of a severe adverse event is defined as a root cause analysis.
This confirms the correct methodology and rules out prospective frameworks or iterative testing models.

Anahtar Kavram

Root cause analysis is a retrospective quality improvement methodology used to investigate adverse and sentinel events by identifying underlying latent systemic vulnerabilities.
Soru 2790Soru →

A 70-year-old male presents to the clinic to establish primary care. He has not seen a physician in over a decade. His past medical history is significant for severe chronic obstructive pulmonary disease (COPD) requiring continuous home oxygen therapy (FEV1 32% of predicted), and ischemic cardiomyopathy with a left ventricular ejection fraction of 25% and NYHA Class III symptoms. He reports being housebound due to dyspnea on minimal exertion. He currently feels at his baseline and denies abdominal pain, changes in bowel habits, or rectal bleeding. A complete blood count reveals a hemoglobin of 14.5 g/dL. He has never undergone colorectal cancer screening but asks if he should be tested now because a close friend was recently diagnosed with colon polyps. Which of the following is the most appropriate next step regarding colorectal cancer screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Advise the patient that screening is not indicated

Cevap

Advise the patient that screening is not indicated due to his severe, life-limiting comorbidities and limited life expectancy.
Colorectal cancer screening is generally recommended for adults aged 45 to 75. However, major medical societies explicitly emphasize that screening should be individualized. It is most appropriate for adults who are healthy enough to undergo treatment if cancer is detected and who do not have life-limiting comorbid conditions. This patient has severe, end-stage cardiopulmonary disease (oxygen-dependent COPD and NYHA Class III heart failure). His life expectancy is severely limited (well under 10 years), meaning he will not realize the long-term mortality benefits of detecting a slow-growing cancer. Furthermore, the procedural risks of colonoscopy (sedation-related respiratory failure or hemodynamic collapse) vastly outweigh the benefits. Because he cannot safely undergo a colonoscopy, even non-invasive initial screening tests are inappropriate, as a positive result cannot be safely evaluated. Therefore, the most appropriate step is to advise against screening.

Adım Adım Çözüm

1
Evaluate the patient's age and general screening indication.
The patient is 70 years old, which falls within the standard age range (45-75 years) for routine colorectal cancer screening.
Age is the primary determinant for initiating routine population-based screening.
2
Assess the patient's overall health status and life expectancy.
The patient has oxygen-dependent COPD and NYHA Class III ischemic cardiomyopathy, significantly limiting his life expectancy to less than 10 years.
Preventive screening requires a sufficient life expectancy (typically > 10 years) for the patient to realize a mortality benefit from the detection and treatment of early-stage cancer.
3
Evaluate the risks associated with the screening pathway.
Diagnostic colonoscopy would carry an unacceptably high risk of sedation-related cardiopulmonary collapse.
If a non-invasive test (like a fecal immunochemical test) is positive, a colonoscopy is mandatory. You cannot safely complete the screening cascade.
4
Determine the most appropriate management plan.
Discontinue or advise against screening through shared decision-making.
When procedural risks outweigh theoretical benefits and life expectancy is short, withholding screening is the standard of care.

Anahtar Kavram

Individualization of cancer screening based on life expectancy and comorbidities.
Soru 2791Soru →

A team of pediatric researchers is investigating a hypothesized link between maternal exposure to a widely used agricultural pesticide during the first trimester of pregnancy and the development of a rare congenital biliary malformation. This specific malformation has an estimated incidence of 1 in 250,000 live births. The pesticide has been in widespread use in specific agricultural regions for over two decades. The investigators have access to a comprehensive state-wide pediatric electronic health record system and aim to determine if an association exists. They need to complete the investigation rapidly due to limited funding. Which of the following epidemiological study designs is the most efficient and appropriate method for this investigation?

Cevabı ve açıklamayı göster

Cevap: Case-control study

Cevap

Case-control study
The correct answer is a case-control study because it is the most statistically and economically efficient design for investigating rare diseases. In this scenario, the incidence of the malformation is exceedingly low (1 in 250,000). A case-control study operates by identifying patients who already have the condition (cases) and matching them to a similar group of patients without the condition (controls). Researchers then look back in time, using the electronic health record system, to compare the frequency of maternal pesticide exposure between the two groups. This circumvents the need to follow a massive denominator of exposed and unexposed individuals.

Adım Adım Çözüm

1
Identify the primary research objective and the specific epidemiological characteristics of the outcome being studied.
The objective is to evaluate a potential association between an exposure (pesticide) and a congenital malformation that is extremely rare (incidence of 1 in 250,000 live births).
The rarity of the outcome is the most critical factor in determining the feasibility and efficiency of various epidemiological study designs.
2
Evaluate the practical constraints of the investigation described in the scenario.
The investigation must be completed rapidly and efficiently due to limited funding, utilizing existing electronic health records.
Study design selection must account for time, cost, and the availability of data.
3
Select the study design that optimally matches these parameters.
A case-control study is selected as the best method.
By identifying individuals who already have the rare disease (cases) and comparing their past exposures to a group without the disease (controls), researchers can evaluate associations efficiently without needing to track an enormous population over time.

Anahtar Kavram

Epidemiological Study Design Selection for Rare Diseases
Soru 2792Soru →

A 54-year-old woman comes to the clinic to discuss her recent laboratory results and health maintenance plan. She has a 10-year history of type 2 diabetes mellitus and chronic kidney disease stage 3a (estimated glomerular filtration rate of 52 mL/min/1.73 m²). Her current medications include metformin, sitagliptin, and lisinopril. Today, her hemoglobin A1c is 9.1%, and her blood pressure is 138/86 mm Hg.

During the visit, the patient expresses frustration: "I know my blood sugar is still high, but I am absolutely terrified of starting insulin. My grandmother started insulin and was on dialysis a year later; I don't want that to happen to me. Instead, I'd rather just take over-the-counter naproxen to help with my new leg pain so I can walk more. Also, I don't think I need to schedule that mammogram you mentioned last time, since nobody in my family has ever had breast cancer."

Which of the following is the most appropriate initial response by the physician?

Cevabı ve açıklamayı göster

Cevap: It sounds like you have significant concerns about insulin leading to dialysis. Can you tell me more about your grandmother's experience?

Cevap

The most appropriate response is to validate the patient's concerns about insulin and dialysis, and ask her to elaborate on her grandmother's experience.
The correct response utilizes patient-centered communication by validating the patient's emotional state and exploring her specific health beliefs (often termed the explanatory model). Many patients associate insulin with end-stage complications because they observe family members starting insulin late in their disease course. By asking the patient to elaborate on her grandmother's experience, the physician builds trust, uncovers the root of the hesitancy, and creates an opportunity to provide targeted health education (e.g., explaining that uncontrolled diabetes, not insulin, causes kidney failure).

Adım Adım Çözüm

1
Analyze the patient's statements and requests.
The patient exhibits insulin hesitancy based on an associative belief (insulin causes dialysis), requests an NSAID for leg pain, and declines breast cancer screening due to lack of family history.
Identifying all clinical and psychological barriers is necessary before formulating a management plan.
2
Evaluate the clinical safety and appropriateness of the patient's requests.
Naproxen is contraindicated due to her chronic kidney disease. Breast cancer screening is indicated at age 54 regardless of family history. New leg pain requires medical evaluation, not assumptions.
Physicians must recognize when patient requests conflict with medical guidelines, contraindications, or safe diagnostic practices.
3
Select the communication strategy that addresses the core emotional barrier without committing clinical errors.
Exploring the patient's illness narrative regarding her grandmother is chosen as the safest and most effective initial step.
Effective health education requires understanding the patient's 'explanatory model' before attempting to correct medical misconceptions or enforce adherence.

Anahtar Kavram

Patient-Centered Interviewing and Health Education
Soru 2793Soru →

A 55-year-old man presents to the clinic for a routine health maintenance visit. His medical history is significant for type 2 diabetes mellitus and primary hypertension. He has a 30-pack-year smoking history and continues to smoke half a pack of cigarettes daily. His surgical history is unremarkable. His last colonoscopy was performed exactly 10 years ago at age 45 and was normal. His immunizations are up to date, including an annual influenza vaccine, a Tdap booster 2 years ago, and a completed recombinant zoster vaccine series at age 50. He has never received a pneumococcal vaccine. His records show a negative one-time hepatitis C antibody test at age 50. He has no specific health complaints, new skin lesions, or vision changes today.

Based on current United States Preventive Services Task Force (USPSTF) and Advisory Committee on Immunization Practices (ACIP) guidelines, which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Screening for lung cancer with low-dose computed tomography (LDCT); Screening for colorectal cancer with colonoscopy; Administration of the 20-valent pneumococcal conjugate vaccine (PCV20)

Cevap

The indicated interventions are screening for lung cancer with low-dose computed tomography (LDCT), screening for colorectal cancer with colonoscopy, and administration of the 20-valent pneumococcal conjugate vaccine (PCV20).
This patient requires multiple preventive interventions based on his age, comorbidities, and social history. According to USPSTF guidelines, annual lung cancer screening with low-dose computed tomography (LDCT) is recommended for adults aged 50 to 80 years with at least a 20 pack-year smoking history who currently smoke or have quit within the past 15 years. This 55-year-old current smoker with a 30 pack-year history meets these criteria. Furthermore, colorectal cancer screening is recommended for average-risk adults aged 45 to 75. Because his last normal colonoscopy was exactly 10 years ago, he is due for repeat screening. Finally, ACIP guidelines state that adults aged 19 to 64 years with certain underlying medical conditions, such as diabetes mellitus and cigarette smoking, should receive a pneumococcal vaccine. As he is vaccine-naive for pneumococcus, administration of the 20-valent pneumococcal conjugate vaccine (PCV20) is indicated.

Adım Adım Çözüm

1
Assess the patient's age and smoking history to determine lung cancer screening eligibility.
The patient is 55 years old, has a 30-pack-year smoking history, and is a current smoker.
USPSTF guidelines require LDCT screening for adults aged 50-80 with a >=20 pack-year history who currently smoke or quit within 15 years.
2
Evaluate the need for colorectal cancer screening.
The patient is 55 and his last normal colonoscopy was 10 years ago.
Standard screening interval for average-risk adults following a normal colonoscopy is 10 years.
3
Review the patient's immunization history and comorbid conditions.
He has diabetes mellitus, is an active smoker, and has never received a pneumococcal vaccine.
ACIP recommends PCV20 for adults 19-64 with specific risk factors such as diabetes or smoking.
4
Evaluate the remaining options against guidelines.
Routine visual skin exam and repeat HCV screening without new risk factors are not routinely recommended by the USPSTF.
Skin cancer screening has insufficient evidence; HCV screening is generally a one-time test for average-risk adults.

Anahtar Kavram

Application of age- and risk-based USPSTF screening and ACIP immunization guidelines for adults in the primary care setting.
Soru 2794Soru →

A 4242-year-old woman is evaluated in the ambulatory clinic due to a three-day history of high fever, severe fatigue, and a painful sore throat. Her medical history is notable for Crohn disease, which has been in clinical remission for the past four years on a stable daily dose of azathioprine. She also has a history of recurrent gout. Three weeks ago, her primary care physician initiated febuxostat to better control her serum uric acid levels. Today, her temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 98/60 mmHg98/60\text{ mmHg}, pulse is 112/min112/\text{min}, and respirations are 20/min20/\text{min}. Physical examination reveals pale conjunctivae and several aphthous ulcers on the buccal mucosa. There is no active joint swelling, erythema, or focal source of infection identified on examination.

Laboratory studies reveal:
Leukocyte count: 1,100/mm31,100/\text{mm}^3 (Absolute neutrophil count: 400/mm3400/\text{mm}^3)
Hemoglobin: 7.8 g/dL7.8\text{ g/dL}
Platelet count: 42,000/mm342,000/\text{mm}^3

Which of the following is the most appropriate next step in the evaluation and management of this patient?

Cevabı ve açıklamayı göster

Cevap: Admit to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics

Cevap

Admit to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics.
The correct action is to admit the patient to the hospital, discontinue azathioprine, and initiate empiric broad-spectrum intravenous antibiotics. This patient has febrile neutropenia (defined as a single oral temperature ≥38.3∘C\ge 38.3^\circ\text{C} or sustained temperature ≥38.0∘C\ge 38.0^\circ\text{C} for 11 hour, coupled with an absolute neutrophil count <500/mm3< 500/\text{mm}^3). This is a medical emergency. The underlying etiology is a severe pharmacokinetic interaction: azathioprine is a prodrug converted to 66-mercaptopurine (66-MP). 66-MP is subsequently degraded into inactive metabolites by the enzyme xanthine oxidase. Febuxostat (like allopurinol) is a xanthine oxidase inhibitor. When co-administered, febuxostat blocks the degradation of 66-MP, leading to massive intracellular accumulation of active thiopurine nucleotides and profound, life-threatening myelosuppression.

Adım Adım Çözüm

1
Evaluate the clinical presentation and vital signs.
The patient is febrile, tachycardic, hypotensive, and severely neutropenic (absolute neutrophil count <500/mm3<500/\text{mm}^3).
To identify that the patient is experiencing a hematologic emergency known as febrile neutropenia, which carries a high risk of rapid progression to septic shock.
2
Analyze the patient's medication list for pharmacokinetic interactions.
The patient was recently started on febuxostat while taking a stable dose of azathioprine.
To pinpoint the etiology of the sudden pancytopenia. Azathioprine is metabolized into 66-mercaptopurine, which is normally inactivated by xanthine oxidase. Febuxostat is a potent xanthine oxidase inhibitor, leading to toxic accumulation of 66-mercaptopurine and profound myelosuppression.
3
Determine the most appropriate setting and sequence for treatment evaluation.
Immediate inpatient admission, cessation of the interacting medications, and rapid administration of empiric broad-spectrum intravenous antibiotics are required.
Febrile neutropenia requires emergent stabilization before any further diagnostic workup (like imaging or biopsies) to prevent mortality.

Anahtar Kavram

Co-administration of azathioprine and xanthine oxidase inhibitors (such as febuxostat or allopurinol) results in a severe pharmacokinetic interaction leading to toxic accumulation of 66-mercaptopurine and life-threatening myelosuppression. The resulting febrile neutropenia is a medical emergency requiring immediate hospitalization and empiric broad-spectrum intravenous antibiotics.
Soru 2795Soru →

Presenting to the nephrology clinic with a 3-day history of hand tremors, headaches, and reduced urine output, a 52-year-old male recipient of a deceased-donor renal allograft undergoes urgent evaluation. He is currently 6 months post-transplantation.

His maintenance immunosuppressive regimen includes tacrolimus, mycophenolate mofetil, and prednisone. Two weeks ago, he was diagnosed with oropharyngeal candidiasis by his primary care physician and completed a 14-day course of oral fluconazole.

Vital signs are:
ParameterValue
Temperature37.1°C (98.8°F)
Blood pressure158/96 mmHg
Pulse84/min

Physical examination reveals a fine resting tremor in the bilateral upper extremities. The transplanted kidney is non-tender to palpation.

Laboratory results:
TestResultReference Range
Potassium5.4 mEq/L3.5-5.0 mEq/L
Blood urea nitrogen48 mg/dL8-20 mg/dL
Serum creatinine3.1 mg/dL0.7-1.3 mg/dL

*Baseline serum creatinine was 1.3 mg/dL one month ago.*

Which of the following is the most appropriate next step in the management and monitoring of this patient?

Cevabı ve açıklamayı göster

Cevap: Order a serum tacrolimus trough level and withhold the next scheduled dose of tacrolimus

Cevap

The most appropriate next step is to order a serum tacrolimus trough level and withhold the next scheduled dose of tacrolimus.
This patient is presenting with acute calcineurin inhibitor (CNI) toxicity. Tacrolimus is metabolized primarily by the hepatic cytochrome P450 3A4 (CYP3A4) system. Fluconazole is a potent inhibitor of CYP3A4. The concurrent use of fluconazole drastically reduces tacrolimus clearance, leading to supratherapeutic levels. CNI toxicity manifests with dose-dependent acute kidney injury (due to afferent arteriolar vasoconstriction), new-onset or worsening hypertension, neurotoxicity (e.g., resting tremors, headaches, seizures), and metabolic derangements such as hyperkalemia. Because the clinical picture strongly points to drug toxicity rather than acute cellular rejection (which would typically present with graft tenderness and fever), the most appropriate next step in monitoring and evaluation is to withhold the next dose of tacrolimus and measure a serum trough level to confirm the diagnosis.

Adım Adım Çözüm

1
Analyze the patient's timeline and new medications.
The patient was recently started on fluconazole, a potent inhibitor of the cytochrome P450 (CYP3A4) enzyme system.
Identifying new medications is critical to uncovering drug-drug interactions in transplant patients.
2
Correlate the new medication with the maintenance regimen.
Tacrolimus is extensively metabolized by CYP3A4. Fluconazole inhibition leads to decreased tacrolimus clearance and supratherapeutic systemic levels.
Understanding the pharmacokinetic pathways reveals the mechanism of potential toxicity.
3
Evaluate the clinical presentation and laboratory results against known toxicities.
The patient exhibits classic signs of calcineurin inhibitor (CNI) toxicity: acute kidney injury (creatinine 3.1 mg/dL), neurotoxicity (tremors, headache), hypertension, and hyperkalemia.
Differentiating CNI toxicity from acute cellular rejection (which typically features graft tenderness and fever) dictates the management pathway.
4
Determine the optimal sequencing for treatment and monitoring.
The immediate priority is to halt the offending agent (withhold tacrolimus) and confirm the diagnosis non-invasively (check trough level) before pursuing invasive biopsies.
Standard of care requires establishing therapeutic drug levels before escalating to immunosuppressive therapies or invasive diagnostics.

Anahtar Kavram

Calcineurin inhibitor toxicity secondary to CYP3A4 inhibition requires immediate dose withholding and serum level monitoring before invasive diagnostics.
Tahmini Süre:2m 0s
Soru 2796Soru →

During morning rounds, an attending physician discusses discharge planning with a 64-year-old male patient who has end-stage heart failure (New York Heart Association class IV). The patient was hospitalized four days ago for a severe exacerbation and has been stabilized on intravenous diuretics, though he continues to experience dyspnea at rest. His recent echocardiogram demonstrates a left ventricular ejection fraction of 15%, and his cardiorenal syndrome has progressed to stage 4 chronic kidney disease. The patient states, "I am tired of coming to the hospital. I know my heart is giving out. I just want to go home and be comfortable, even if it means my time is short." The physician conducts a thorough evaluation and determines that the patient clearly understands his medical condition, prognosis, and the consequences of foregoing further acute care. Later that afternoon, the patient's adult daughter, who is his emergency contact, privately tells the physician, "He is just depressed because he's been in the hospital for days. You can't let him go home to die. I want him transferred to a rehabilitation center to get stronger. I am his daughter, and I have the right to decide this." Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Proceed with discharging the patient to home with community hospice services.

Cevap

Proceed with discharging the patient to home with community hospice services.
This patient has a terminal illness (end-stage heart failure and chronic kidney disease) and has clearly expressed a desire for comfort-focused care at home. The attending physician has evaluated the patient and determined that he has intact clinical decision-making capacity—meaning he fully understands his diagnosis, prognosis, and the consequences of his decisions. When a patient possesses clinical capacity, the ethical principle of autonomy dictates that their choices regarding medical care must be honored, even if family members strongly disagree. Therefore, the most appropriate next step is to respect the patient's autonomy and arrange for home hospice services as he requested.

Adım Adım Çözüm

1
Identify the patient's clinical status and articulated goals of care.
The patient has terminal heart failure and explicitly requests comfort-focused end-of-life care at home.
Establishing the patient's core medical status and wishes is the foundation for determining appropriate disposition.
2
Evaluate the patient's decision-making capacity based on the clinical assessment.
The attending physician has already confirmed that the patient understands his prognosis and the consequences of his decisions.
Before acting on a patient's wishes, it is necessary to ensure they possess the clinical capacity to make informed medical decisions.
3
Apply the principles of medical ethics regarding patient autonomy versus surrogate authority.
The daughter's demands cannot override the patient's choices, and the discharge should proceed as the patient requested.
A surrogate decision-maker is only activated when a patient loses capacity. Since this patient retains capacity, his autonomous decisions are legally and ethically binding.

Anahtar Kavram

In end-of-life care, a patient with intact clinical decision-making capacity has the paramount right to refuse life-prolonging care and dictate their disposition, superseding any objections from family members or designated surrogates.
Tahmini Süre:1m 30s
Soru 2797Soru →

An otherwise healthy 42-year-old woman visits the outpatient clinic for a scheduled check-up. She has no significant past medical history, takes no medications, and has no family history of cancer. She reports feeling completely well with no abdominal pain, bloating, or changes in bowel habits. However, she appears visibly distressed during the encounter. She states, "My best friend was just diagnosed with advanced ovarian cancer. I am terrified that I might have it too without knowing. I read online that there is a blood test for CA-125 and an ultrasound that can detect it early, and I want them done today." Which of the following is the most appropriate physician response?

Cevabı ve açıklamayı göster

Cevap: It is completely understandable to be frightened after your friend's diagnosis. Let's discuss how ovarian cancer screening works and why these specific tests are not recommended for you.

Cevap

The most appropriate response is to validate the patient's fear and initiate a discussion about why routine ovarian cancer screening is not recommended.
The correct approach to a patient expressing health anxiety driven by a peer's illness is to first validate their emotional distress using an empathetic statement, followed by patient education. According to the United States Preventive Services Task Force (USPSTF), routine screening for ovarian cancer with CA-125 and transvaginal ultrasound is strongly recommended against in asymptomatic, average-risk women. This is because screening does not reduce disease-specific mortality and carries a high risk of false-positive results, which can lead to unnecessary surgical interventions and severe psychological harm. By acknowledging the patient's fear and gently transitioning to a discussion of the medical evidence, the physician upholds both the therapeutic alliance and evidence-based practice.

Adım Adım Çözüm

1
Identify the patient's core concern and emotional state.
The patient is highly anxious about ovarian cancer due to a peer's recent diagnosis, despite having no symptoms or elevated risk factors.
Effective patient counseling requires addressing underlying emotions before delivering medical facts.
2
Evaluate the medical appropriateness of the requested intervention.
The USPSTF recommends against routine screening for ovarian cancer in asymptomatic, average-risk women because it does not reduce mortality and leads to harmful false positives.
Physicians must adhere to evidence-based preventive guidelines and avoid low-value care.
3
Select the communication strategy that merges empathy with education.
Acknowledge her understandable fear, then pivot to collaborative health education regarding why the tests are more likely to cause harm than benefit.
This maintains the therapeutic alliance while fulfilling the physician's duty to provide standard-of-care medical advice.

Anahtar Kavram

Empathetic communication and evidence-based patient education in the setting of low-value care requests.

Alternatif Yöntem

When addressing requests for low-value care, use the 'NURSE' mnemonic for empathy (Name, Understand, Respect, Support, Explore) followed by the 'Ask-Tell-Ask' framework for delivering health information.
Tahmini Süre:1m 0s
Soru 2798Soru →

Match each patient statement or scenario representing a stage in the Transtheoretical Model of Change (left) with the most appropriate physician counseling strategy (right).

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with alcoholic hepatitis says, "I know drinking is hurting my liver, but I really enjoy socializing with my friends at the bar."
A 32-year-old woman says, "I bought a gym membership and new running shoes yesterday, but I am not sure exactly when I will start working out."
A 55-year-old man with uncontrolled hypertension says, "I feel perfectly fine, so I do not see why I need to take these blood pressure pills."
A 28-year-old woman says, "I stopped vaping three months ago, but sometimes I still get strong urges when I am stressed at work."

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The scenarios match their respective stages of change: Precontemplation (unaware of problem) matches with providing information without pressure; Contemplation (ambivalent) matches with exploring pros and cons; Preparation (getting ready) matches with setting a specific start date; Action (recently changed) matches with relapse prevention and coping strategies.
Matching the counseling strategy to the patient's specific readiness stage maximizes the effectiveness of the intervention. Precontemplation requires gentle awareness-building; contemplation requires exploring ambivalence; preparation requires concrete planning; and action requires relapse prevention.

Adım Adım Çözüm

1
Analyze the hypertension patient's statement.
The patient feels fine and sees no reason for medication (Precontemplation).
Identifying the stage of change dictates the counseling approach, which should focus on raising awareness without confrontation.
2
Analyze the alcoholic hepatitis patient's statement.
The patient knows drinking is harmful but enjoys the social aspect (Contemplation).
Recognizing ambivalence directs the physician to explore the pros and cons to help the patient resolve their indecision.
3
Analyze the gym membership patient's statement.
The patient has taken initial steps but hasn't fully started (Preparation).
Patients in this stage benefit most from concrete planning and establishing a firm start date.
4
Analyze the vaping cessation patient's statement.
The patient has maintained the change for three months but faces triggers (Action).
During the action phase, the primary goal is relapse prevention through the development of coping skills.

Anahtar Kavram

Transtheoretical Model (Stages of Change) and Stage-Matched Interventions
Soru 2799Soru →

A clinical research team is designing a study to evaluate two new therapies for major depressive disorder: a novel oral serotonin-norepinephrine reuptake inhibitor (Drug A) and a new non-invasive transcranial magnetic stimulation protocol (Device B). They randomize 800 patients with moderate-to-severe depression into four distinct groups: Drug A plus a sham device, Device B plus a placebo pill, Drug A plus Device B, and a placebo pill plus a sham device. The primary endpoint is the mean reduction in the Hamilton Depression Rating Scale (HAM-D) score at 12 weeks. Which of the following best describes the primary methodological advantage that this specific study design provides over conducting two separate, independent randomized controlled trials?

Cevabı ve açıklamayı göster

Cevap: It provides the ability to formally assess for effect modification between the pharmacological and device-based interventions

Cevap

It provides the ability to formally assess for effect modification between the pharmacological and device-based interventions
The study described is a 2x2 factorial randomized controlled trial. In this design, patients are randomized to receive either intervention A, intervention B, both interventions, or neither. The primary methodological advantage of a factorial design over conducting two separate, parallel randomized controlled trials is its ability to efficiently evaluate both the independent 'main effects' of each intervention and the 'interaction' between them. In clinical epidemiology and biostatistics, this interaction is synonymous with effect modification. By utilizing this design, the investigators can formally test whether the effect of the oral medication on depression scores is different (e.g., synergistic or antagonistic) when given concurrently with the magnetic stimulation device compared to when it is given alone.

Adım Adım Çözüm

1
Identify the study design described in the vignette.
The researchers randomized patients into four groups receiving different combinations of two interventions (Drug A alone, Device B alone, both, or neither). This is a 2x2 factorial randomized controlled trial.
Recognizing the trial architecture is necessary to understand its specific methodological strengths and limitations.
2
Determine the unique statistical and clinical advantages of this specific design.
A factorial design allows for the evaluation of the 'main effect' of each intervention independently, as well as the 'interaction effect' (effect modification) between the two interventions.
This is the primary reason investigators choose a factorial design over conducting two separate trials, as two separate parallel trials cannot assess whether the therapies work synergistically or antagonistically.
3
Evaluate the options to find the one that accurately describes this advantage while avoiding common statistical and clinical misconceptions.
The option describing the assessment for effect modification correctly identifies the unique advantage of the factorial design.
Other options incorrectly describe statistical principles (confusing confounding with effect modification, misapplying t-tests, misunderstanding PPV) or pharmacologic principles.

Anahtar Kavram

Factorial Study Design and Effect Modification
Soru 2800Soru →

Match each ambulatory patient presentation with the most appropriate next step in preventive care and screening according to current guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 35-year-old male presents for a wellness visit. He is asymptomatic. His father was recently diagnosed with colorectal cancer at age 42. He has never undergone endoscopic screening.
A 68-year-old female presents for an annual examination. She has never smoked and has no cardiovascular history. She asks if she needs an ultrasound to screen for an abdominal aortic aneurysm.
A 28-year-old female at 28 weeks gestation in her second pregnancy presents for routine prenatal care. She received all recommended vaccines, including Tdap, during her first pregnancy three years ago.
A 62-year-old female presents for a health maintenance visit. She underwent a total abdominal hysterectomy for benign uterine leiomyomas five years ago. Prior cervical cytology results were consistently normal.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align each patient with their specific evidence-based preventive intervention: The 35-year-old male requires immediate colonoscopy with 5-year surveillance; the 68-year-old female never-smoker requires no AAA screening; the pregnant female requires a Tdap vaccine regardless of prior doses; and the post-hysterectomy female should discontinue cervical screening.
Each presentation tests a specific caveat to routine screening and vaccination guidelines. High-risk colorectal screening requires initiation 10 years before the youngest affected first-degree relative and requires 5-year colonoscopy intervals. AAA screening is actively recommended against in female never-smokers. Tdap is mandated for every pregnancy to protect the newborn, irrespective of the mother's standard 10-year booster status. Total hysterectomy for benign indications necessitates the cessation of Pap smears.

Adım Adım Çözüm

1
Analyze the 35-year-old male's family history of colorectal cancer.
Identify that a first-degree relative diagnosed at age 42 dictates screening initiation at age 32 (10 years prior) with a colonoscopy every 5 years.
High-risk family history alters both the initiation age and the interval of colorectal cancer screening.
2
Evaluate the 68-year-old female's request for an abdominal aortic aneurysm (AAA) screening.
Determine that AAA screening is contraindicated.
Guidelines strictly recommend against AAA screening in females who have never smoked due to negligible benefit and potential harm from incidental findings.
3
Assess the vaccination requirements for the 28-year-old female at 28 weeks gestation.
Determine she requires a Tdap vaccine today despite having received one 3 years ago.
Maternal pertussis antibodies wane quickly; a new dose is required during the 27-36 week window of every pregnancy to protect the neonate.
4
Review the 62-year-old female's surgical and screening history.
Conclude that cervical cancer screening can be permanently discontinued.
A total hysterectomy for benign disease (e.g., leiomyomas) removes the cervix, eliminating the need for screening in the absence of a high-grade dysplastic history.

Anahtar Kavram

Application of preventive care exceptions based on high-risk family history, patient sex and smoking status, pregnancy, and past surgical history.
ÖncekiSayfa 140 / 237Sonraki